background treatment bladder cancer NUMBER converging pion beams expected certain advantages possibly fewer effects high let radiation therapies neutrons results early results promising NUMBER NUMBER NUMBER evaluable patients sessile invasive bladder carcinomas clinically complete responses NUMBER NUMBER NUMBER evaluable patients superficial bladder tumors clinically complete responses article reports followup years patients emphasis late effects pion radiation therapy NUMBER NUMBER patients treated died median survival time NUMBER months range months seventeen NUMBER died metastatic disease instances combined local recurrence months radiation therapy NUMBER died locally progressive disease NUMBER died late effects radiation therapy months treatment patients treated NUMBER pion gy generally interval months observed effects severe consisting chronic inflammation vascular damage pelvic region followed ulceration fistulas perforations intestines NUMBER patients cystectomy urinary diversion necessary excessive fibrosis bladder shrinkage patients colostomy required stenotic inflammatory disease necrosis perforations intestines remaining patients NUMBER died causes unrelated primary disease months radiation therapy conclusions results phase trial using swiss piotron showed high complete response rate patients sessile bladder cancers high incidence local recurrences severe instances lethal effects expected results basis future improvements particularly regarding dosing fractionation experience emphasizes need sufficiently long observation period reaching conclusions high let treatment neutron pion heavy ion radiation therapy dose distribution linear energy transfer long term NUMBER NUMBER thirty NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER symptom free NUMBER NUMBER NUMBER NUMBER ii